Table 2. sup-18(lf) mutations exhibit dosage-dependent suppression of the locomotory defects of sup-10(n983gf) mutant.

Genotype	LR ± SEM	n
Wild-type	33.0±1.2	36
sup-10(n983gf)	4.7±0.9	25
sup-18(n1030); sup-10(n983gf)	31.7±0.7	15
sup-18(n1030)/+; sup-10(n983gf)	15.2±0.7	25
sup-18(n1033)/+; sup-10(n983gf)	13.8±0.6	25
sup-18(n1014)/+; sup-10(n983gf)	14.6±0.6	25
sup-18(n1036)/+; sup-10(n983gf)	12.3±0.7	25
sup-18(n1471)/+; sup-10(n983gf)	14.0±0.7	25
sup-9(n1913); sup-10(n983gf)	33.2±1.1	15
sup-9(n1913)/+; sup-10(n983gf)	5.6±0.6	20
unc-93(e1500gf); sup-10(n4025)	10.0±0.5	30
unc-93(e1500gf) sup-18(n1030)/+; sup-10(n4025)	9.8±0.7	20
unc-93(e1500gf) sup-18(n1030); sup-10(n4025)	17.5±0.9	30
sup-9(n1550gf)/+	3.8±0.5	24
sup-9(n1550gf)/+; sup-18(n1030)/+	5.0±0.5	39
sup-9(n1550gf)/+; sup-18(n1030)	9.8±0.5	22

Young adult males were assayed for the number of bends made on a bacterial lawn during 1 min interval. LR: locomotory rate (bodybends/min).